Protox Therapeutics Inc. |
(PRX.-TSX-VEN) |
2Q to Jun. 30 | Year ago | |
Revenue | 36,000 | 16,000 |
Net profit | (1,478,000) | (1,549,000) |
Net prf/shr | (0.04) | (0.07) |
Protox Therapeutics Inc. |
(PRX.-TSX-VEN) |
2Q to Jun. 30 | Year ago | |
Revenue | 36,000 | 16,000 |
Net profit | (1,478,000) | (1,549,000) |
Net prf/shr | (0.04) | (0.07) |